Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.

Omar Chibani1, Jeffrey F Williamson

  • 1Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, USA. ochibani@vcu.edu

Medical Physics
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose Prediction in Proton Cancer Therapy based on Density Maps from Dual-energy CT Using Joint Statistical Image Reconstruction.

Proceedings of SPIE--the International Society for Optical Engineering·2025
Same author

Derivation of tissue properties from basis-vector model weights for dual-energy CT-based Monte Carlo proton beam dose calculations.

Biomedical physics & engineering express·2025
Same author

Derivation of Tissue Properties from Basis-Vector Model Weights for Dual-Energy CT-Based Monte Carlo Proton Beam Dose Calculations.

ArXiv·2025
Same author

IConDiffNet: an unsupervised inverse-consistent diffeomorphic network for medical image registration.

Physics in medicine and biology·2025
Same author

MB-DECTNet: a model-based unrolling network for accurate 3D dual-energy CT reconstruction from clinically acquired helical scans.

Physics in medicine and biology·2023
Same author

Improving the Scientific Impact of Medical Physics: Challenges and Opportunities: Editor-in-Chief 2014-2020.

Medical physics·2023

A new Monte Carlo code (MCPI) enables rapid, accurate dose calculations for prostate brachytherapy. This tool accounts for complex factors like seed attenuation and tissue variations, improving treatment planning.

Area of Science:

  • Medical Physics
  • Computational Biology
  • Radiotherapy Oncology

Background:

  • Accurate dose calculation is critical for effective prostate brachytherapy.
  • Traditional methods can be computationally intensive, limiting real-time treatment planning.
  • Accounting for tissue heterogeneity and seed interactions is essential for precise dosimetry.

Purpose of the Study:

  • To develop and validate an accelerated Monte Carlo code (MCPI) for rapid and accurate dose calculation in prostate brachytherapy.
  • To assess the impact of interseed attenuation, tissue composition, and calcifications on dose distribution.
  • To enable sub-minute dose calculations for improved treatment planning and assessment.

Main Methods:

  • Developed MCPI, an accelerated Monte Carlo code simulating radioactive seeds in a 3D heterogeneous phantom.

Related Experiment Videos

  • Employed a hybrid geometry model for rigorous treatment of interseed attenuation and tissue heterogeneity.
  • Benchmarked MCPI against MCNP5 for 103Pd and 125I seeds, evaluating speed and accuracy.
  • Quantified dosimetric effects of various factors using MCPI simulations.
  • Main Results:

    • MCPI achieves dose calculations over 1000 times faster than MCNP5 for prostate brachytherapy.
    • Calculations for a 103Pd implant (83 seeds) completed in 59 seconds with 2% uncertainty.
    • Ignoring interseed attenuation or minor tissue variations can decrease D100 by 6%.
    • Prostate calcifications (1%-5% volume) significantly reduce D80, D90, and D100 by up to 58%.

    Conclusions:

    • Sub-minute dose calculations are feasible for prostate brachytherapy using the MCPI code.
    • MCPI accurately accounts for critical dosimetric effects, including interseed attenuation and tissue heterogeneity.
    • The code facilitates more precise dose planning and assessment, potentially improving patient outcomes.